Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease?

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 3, 2009, Pages 387-393

  Perez Padilla, Rogelio ^a   Vollmer, W M ^b   Vazquez Garcia J C ^a   Enright, P L ^c   Menezes, A M B ^d   Buist, A S ^e  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

BOLD; COPD; PEF; PLATINO; Screening

Indexed keywords

TOBACCO SMOKE;

ADULT; AGED; ARTICLE; ASTHMA; BIOMASS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DUST; EMPHYSEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PREDICTION AND FORECASTING; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCREENING; SPIROMETER; SPIROMETRY; WORKPLACE;

AGED; AIRWAY OBSTRUCTION; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

EID: 62349140040     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Global Initiative for Chronic Obstructive Lung Disease. Workshop report, global strategy for diagnosis, management and prevention of COPD. http://www.goldcopd.com/Bethesda, MD, USA: NHLBI, NIH & WHO, 2007.
2. Talamo C, de Oca M M, Halbert R, et al. Diagnostic labeling of COPD in five Latin American cities. Chest 2007; 131: 60-67.
3. Liistro G, Vanwelde C, Vincken W, et al. Technical and functional assessment of 10 office spirometers: a multicenter comparative study. Chest 2006; 130: 657-665.
4. Boffin N, Van der Stighelen V, Paulus D, et al. Use of office spirometers in Flemish general practice: results of a telephone survey. Monaldi Arch Chest Dis 2006; 65: 128-132.
5. Chuaychoo B, Maranetra N, Naruman C, et al. The most cost-effective screening method for chronic obstructive pulmonary disease among the Bangkok elderly. J Med Assoc Thai 2003; 86:1140-1148.
6. Jackson H, Hubbard R. Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey. BMJ 2003; 327: 653-654.
7. Menezes A M, Perez-Padilla R, Jardim J R, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-1881.
8. Buist A S, Vollmer W M, Sullivan S D, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005; 2: 277-283.
9. Menezes A M, Victora C G, Perez-Padilla R. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol 2004; 4: 15.
10. Perez-Padilla R, Vazquez-Garcia J C, Marquez M N, et al. The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care 2006; 51: 1167-1171.
11. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
12. Miller M R, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
13. Hankinson J L, Odencrantz J R, Fedan K B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187.
14. Ferguson G T, Enright P L, Buist A S, et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000; 117: 1146-1161.
15. Ramirez-Venegas A, Sansores R H, Perez-Padilla R, et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 2006; 173: 393-397.
16. Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2007; 147: 633-638.
17. Price D B, Tinkelman D G, Halbert R J, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration 2006; 73: 285-295.
18. Pinto-Plata V M, Celli-Cruz R A, Vassaux C, et al. Differences in cardiopulmonary exercise test results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease stage categories and gender. Chest 2007; 132: 1204-1211.
19. Mannino D M, Reichert M M, Davis K J. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med 2006; 173: 985-990.
20. Miravitlles M, Calle M, Alvarez-Gutierrez F, et al. Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease. Qual Life Res 2006; 15: 471-480.
21. Mannino D M, Doherty D E, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006; 100: 115-122.
22. Calverley P M, Anderson J A, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789.
23. 1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
24. Wilt T J, Niewoehner D, Kane R L, et al. Spirometry as a motivational tool to improve smoking cessation rates: a systematic-review of the literature. Nicotine Tob Res 2007; 9: 21-32.
25. Lin K, Watkins B, Johnson T, et al. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2008; 148: 535-543.
26. de la Iglesia F, Diaz J L, Pita S, et al. Peak expiratory flow rate as predictor of inpatient death in patients with chronic obstructive pulmonary disease. South Med J 2005; 98: 266-272.
27. Emerman C L, Cydulka R K. Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease. Ann Emerg Med 1996; 27: 159-163.
28. Murata G H, Lium D J, Busby H K, et al. Precision and accuracy of self-measured peak expiratory flow rates in chronic obstructive pulmonary disease. South Med J 1998; 91: 919-924.
29. Miller M R, Jones B, Xu Y, et al. Peak expiratory flow profiles delivered by pump systems. Limitations due to wave action. Am J Respir Crit Care Med 2000; 161: 1887-1896.